Global Health Risk Framework

The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises

Videos from U.S. and Asia Report Release Events

About the Report

The Ebola crisis in West Africa was both a tragedy and a wakeup call, revealing dangerous deficiencies across global systems to prevent, prepare, and respond to infectious disease crises. To address these shortcomings and inform a more effective response in the future, the National Academy of Medicine convened the Commission on a Global Health Risk Framework for the Future (GHRF Commission)—an independent, international group of experts in finance, governance, R&D, health systems, and the social sciences.

The Commission’s report, which was published on January 13, highlights the essential role of pandemic preparedness in national security and economic stability—a critical but often under-examined dimension of the global conversation post-Ebola. Importantly, the report demonstrates that the impact of infectious disease crises goes far beyond human health alone—and that mitigation, likewise, requires the mobilization and long-term commitment of multiple sectors.

Commissioners

The GHRF Commission is made up of 17 international experts in governance; finance; disease control; surveillance; workforce mobilization; humanitarian and pandemic response; health systems; public-private partnerships; social science; and research, development, acquisition, and distribution. Commissioners were screened for conflicts of interest to ensure their independence. See commissioner biographies >>

Peter Sands, MPA (Chair)
Former Group Chief Executive Officer
Standard Chartered PLC
Senior Fellow
Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School

Oyewale Tomori, DVM, PhD (Vice Chair)
President
Nigeria Academy of Sciences

Ximena Aguilera, MD
Director, Center of Epidemiology and Public Health Policies
Universidad del Desarrollo, Chile

Irene Akua Agyepong, DrPh, MBChB, FGCPS
Greater Accra Regional Health Directorate
Ghana Health Service

Yvette Chesson Wureh, JD
Establishment Coordinator
Angie Brooks International Centre for Women’s Empowerment, Leadership Development, International Peace & Security
C/O The University of Liberia

Paul Farmer, MD, PhD
Kolokotrones University Professor and Chair of the Department of Global Health and Social Medicine
Harvard Medical School
Cofounder of Partners in Health

Maria Freire, PhD
President
Foundation for the National Institutes of Health

Julio Frenk, MD, MPH, PhD
President
University of Miami

Lawrence Gostin, JD
University Professor of Global Health Law
Georgetown University
Faculty Director
O’Neill Institute on National and Global Law

Gabriel Leung, MD, MPH
Dean
Li Ka Shing Faculty of Medicine
University of Hong Kong

Francis Omaswa, MBBCh, MMed, FRCS, FCS
Executive Director
African Center for Global Health and Social Transformation

Melissa Parker, DPhil
Reader in Medical Anthropology
Department of Global Health and Development
London School of Hygiene & Tropical Medicine

Sujatha Rao, MA, MPA
Former Secretary
Ministry of Health and Family Welfare of India

Daniel Ryan, MA
Head of R&D – Life & Health and Big Data
Swiss Re

Jeanette Vega, MD, MPH, PhD
Director
Chilean National Health Fund

Suwit Wibulpolprasert, MD
Vice Chair
International Health Policy Program Foundation
Health Intervention and Technology Assessment
Ministry of Public Health, Thailand

Tadataka Yamada, MD
Venture Partner
Frazier Life Sciences

 

Staff

Ceci Mundaca-Shah, Project Director
V. Ayano Ogawa, Associate Program Officer
Patrick Kelley, Director, Board on Global Health

 

International Oversight Group

The NAM formed an International Oversight Group (IOG), a global body of experts, to ensure the independence and objectivity of the Commission, and to protect integrity and maintain public confidence in the process.

  • Victor Dzau (Chair), President, National Academy of Medicine
  • Judith Rodin (Vice-Chair), President, Rockefeller Foundation
  • Fazle Hasan Abed, Founder of BRAC and Chairman of BRAC Bank Limited
  • Arnaud Bernaert, Senior Director, Head of Global Health and Healthcare Industries, World Economic Forum 
  • Chris Elias, President of the Global Development Program, Bill & Melinda Gates Foundation
  • Jeremy Farrar, President, Wellcome Trust 
  • Shigeru Omi, President, Japan Community Health Care Organization
  • Paul Polman, CEO, Unilever
  • Tan Chorh Chuan, President, National University of Singapore
  • Miriam Were, Chancellor, Moi University
  • Mirta Roses, Former Director-General, Pan American Health Organization
  • Shen Xiaoming, Professor of Pediatrics, Xin Hua Hospital and Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine

Evidence-Gathering Workshops

As part of its workplan, the Commission received input from four Institute of Medicine workshops on the following topics:

Governance for global health. The first workshop explored global, national, and local capabilities to facilitate the collective action of governmental, intergovernmental, corporate, and nonprofit sectors as they contribute to preparedness and response.

Financing response to pandemic threats. The second workshop examined public- and private-sector roles in financing preparedness and response to epidemics. Topics included financing mechanisms for public health surveillance, workforce mobilization, and acquisition of medical commodities that can channel funds swiftly while minimizing transaction times and other expenses.

Resilient health systems. The third workshop explored integrated surveillance and health information systems; workforce capacity; health system infrastructure; community, regional, and global partner engagement; and supply chain coordination and management.

Research and development of medical products. The final workshop assessed current product development platforms; explore incentives and infrastructure for product development and conditions and needs for effective public-private partnerships; and addressed standards and approaches for regulatory harmonization and systems capacity.

To develop its report, the commission considered evidence supplied by the workshops and lessons learned from the recent Ebola outbreak and other outbreaks of global impact, such as H1N1 influenza, Middle East Respiratory Syndrome (MERS), and Severe Acute Respiratory Syndrome (SARS). The commission deliberated and evaluated options to strengthen global, regional, national, and local systems to better prepare, detect, and respond to epidemic infectious diseases. Ultimately, the report will furnish conclusions and actionable recommendations to guide policy makers, international funders, civil society organizations, and the private sector.


Join Our Community

Sign up for NAM email updates